Biophysical and biochemical screening for the risk of preterm labor

Clinics in Laboratory Medicine

Volumn 30, Issue 3, 2010, Pages 693-707

  Wax, Joseph R ^a   Cartin, Angelina ^a   Pinette, Michael G ^a  

^a MAINE MEDICAL CENTER   (United States)

Author keywords

Cervical cerclage; Cervical length; Fetal fibronectin; Preterm birth; Progesterone; Ultrasound

Indexed keywords

BIOLOGICAL MARKER; FIBRONECTIN; INTERLEUKIN 8; PLACEBO; PROGESTERONE; FFN PROTEIN, HUMAN;

BIOCHEMISTRY; CERVICAL LENGTH MEASUREMENT; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENDOMETRIAL DISEASE; FEMALE GENITAL TRACT INFECTION; FETAL BIOPHYSICAL PROFILE; FETUS MONITORING; GESTATIONAL AGE; HEALTH CARE COST; HUMAN; LENGTH OF STAY; MATERNAL TREATMENT; OBSTETRIC HEMORRHAGE; PERINATAL MORTALITY; PREDICTION; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PREMATURITY; PRENATAL SCREENING; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SCORING SYSTEM; TRANSVAGINAL ECHOGRAPHY; UTERINE CERVIX CERCLAGE; UTERUS DISEASE; FEMALE; OBSTETRIC LABOR, PREMATURE; PREDICTIVE VALUE; PREGNANCY; PRENATAL DIAGNOSIS; PROCEDURES;

CERVICAL LENGTH MEASUREMENT; FEMALE; FIBRONECTINS; HUMANS; OBSTETRIC LABOR, PREMATURE; PREDICTIVE VALUE OF TESTS; PREGNANCY; PRENATAL DIAGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 77954777898     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2010.04.006     Document Type: Review

References (51)

1. Hamilton BE, Martin JA, Ventura SJ. Births: preliminary data for 2007. National vital statistics reports, March 18, 2009. Available at: Accessed April 28, 2010. http://www.cdc.gov/nchs/data/nvsr/nvsr57/nvsr57_12.pdf.
2. Iams J.D. Prediction and early detection of preterm labor. Obstet Gynecol 2003, 101:402-412.
3. Iams J.D., Johnson F.F., Sonek J., et al. Cervical competence as a continuum: a study of ultrasonographic cervical length and obstetric performance. Am J Obstet Gynecol 1995, 172(4 Pt 1):1097-1106.
4. Iams J.D., Goldenberg R.L., Meis P.J., et al. The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. N Engl J Med 1996, 334(9):567-572.
5. Romero R., Kusanovic J.P., Espinoza J., et al. What is amniotic fluid 'sludge'?. Ultrasound Obstet Gynecol 2007, 30(5):793-798.
6. Kusanovic J.P., Espinoza J., Romero R., et al. Clinical significance of the presence of amniotic fluid 'sludge' in asymptomatic patients at high risk for spontaneous preterm delivery. Ultrasound Obstet Gynecol 2007, 30(5):706-714.
7. Yost N.P., Bloom S.L., Twickler D.M., et al. Pitfalls in ultrasonic cervical length measurement for predicting preterm birth. Obstet Gynecol 1999, 93(4):510-516.
8. Ascarelli M.H., Morrison J.C. Use of fetal fibronectin in clinical practice. Obstet Gynecol Surv 1997, 52(Suppl 4):S1-S12.
9. Sanchez-Ramos L., Delke I., Zamora J., et al. Fetal fibronectin as a short-term predictor of preterm birth in symptomatic patients: a meta-analysis. Obstet Gynecol 2009, 114(3):631-640.
10. Goldenberg R.L., Mercer B.M., Meis P.J., et al. The preterm prediction study: fetal fibronectin testing and spontaneous preterm birth. NICHD Maternal Fetal Medicine Units Network. Obstet Gynecol 1996, 87(5 Pt 1):643-648.
11. Singer E., Pilpel S., Bsat F., et al. Accuracy of fetal fibronectin to predict preterm birth in twin gestations with symptoms of labor. Obstet Gynecol 2007, 109(5):1083-1087.
12. Stafford I.P., Garite T.J., Dildly G.A., et al. A comparison of speculum and nonspeculum collection of cervicovaginal specimens for fetal fibronectin testing. Am J Obstet Gynecol 2008, 199(2). 131, e1-4.
13. Roman A.S., Koklanaris N., Paidas M.J., et al. " Blind" vaginal fetal fibronectin as a predictor of spontaneous preterm delivery. Obstet Gynecol 2005, 105(2):285-289.
14. Management of preterm labor. Obstet Gynecol 2003, 101(5 Pt 1):1039-1047. ACOG Practice Bulletin No. 43.
15. Joffe G.M., Jacques D., Bemis-Heys R., et al. Impact of the fetal fibronectin assay on admissions for preterm labor. Am J Obstet Gynecol 1999, 180(3 Pt 1):581-586.
16. Incerti M., Ghidini A., Korker V., et al. Performance of cervicovaginal fetal fibronectin in a community hospital setting. Arch Gynecol Obstet 2007, 275(5):347-351.
17. Abenhaim H.A., Morin L., Benjamin A. Does availability of fetal fibronectin testing in the management of threatened preterm labor affect the utilization of hospital resources?. J Obstet Gynaecol Can 2005, 27(7):689-694.
18. Mozurkewich E.L., Naglie G., Krahn M.D., et al. Predicting preterm birth: a cost-effectiveness analysis. Am J Obstet Gynecol 2000, 182(6):1589-1598.
19. Lowe M.P., Zimmerman B., Hansen W. Prospective randomized controlled trial of fetal fibronectin on preterm labor management in a tertiary care center. Am J Obstet Gynecol 2004, 190(2):358-362.
20. Owen J., Iams J.D., Hauth J.C. Vaginal sonography and cervical incompetence. Am J Obstet Gynecol 2003, 188(2):586-596.
21. Premature rupture of membranes. Obstet Gynecol 2007, 109(4):1007-1019. ACOG Practice Bulletin No. 80.
22. Management of stillbirth. Obstet Gynecol 2009, 113(3):748-761. ACOG Practice Bulletin No. 102.
23. Harger J.H. Cerclage and cervical insufficiency: an evidence-based analysis. Obstet Gynecol 2003, 100(6):1313-1327.
24. Berghella V., Odibo A.O., To M.S., et al. Cerclage for short cervix on ultrasonography: meta-analysis of trials using individual patient-level data. Obstet Gynecol 2005, 106(1):181-189.
25. Owen J., Hankins G., Iams J.D., et al. Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened mid-trimester cervical length. Am J Obstet Gynecol 2009, 201. 375, e1-8.
26. Cervical insufficiency. Obstet Gynecol 2003, 102(5 Pt 1):1091-1099. ACOG Practice Bulletin No. 48.
27. Sjoborg K.D., Vistad I., Myhr S.S., et al. Pregnancy outcome after cervical cone excision: a case-control study. Acta Obstet Gynecol Scand 2007, 86(4):423-428.
28. Berghella V., Pereira L., Gariepy A., et al. Prior cone biopsy: prediction of preterm birth by cervical ultrasound. Am J Obstet Gynecol 2004, 191(4):1393-1397.
29. Crane J.M. Pregnancy outcome after loop electrosurgical excision procedure: a systematic review. Obstet Gynecol 2003, 102(5 Pt 1):1058-1062.
30. Samson S.A., Bentley J.R., Fahey T.J., et al. The effect of loop electrosurgical excision procedure on future pregnancy outcome. Obstet Gynecol 2005, 105(2):325-332.
31. Noehr B., Jensen A., Fredericksen K., et al. Loop electrosurgical excision of the cervix and risk for spontaneous preterm delivery in twin pregnancies. Obstet Gynecol 2009, 114(3):511-515.
32. Jakobsson M., Gissler M., Paavonen J., et al. Loop electrosurgical excision procedure and the risk for preterm birth. Obstet Gynecol 2009, 114(3):504-510.
33. Sakai M., Shiozaki A., Tabata M., et al. Evaluation of effectiveness of prophylactic cerclage of a short cervix according to interleukin-8 in cervical mucus. Am J Obstet Gynecol 2006, 194(1):14-19.
34. Keeler S.M., Roman A.S., Coletta J.M., et al. Fetal fibronectin testing in patients with short cervix in the midtrimester: can it identify optimal candidates for ultrasound-indicated cerclage?. Am J Obstet Gynecol 2009, 200(2). 158, e1-6.
35. Meis P.J., Klebanoff M., Thom E., et al. Prevention of recurrent preterm birth by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003, 348(24):2379-2385.
36. Norman J.E., Mackenzie F., Owen P., et al. Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomized, double-blind, placebo controlled study and meta-analysis. Lancet 2009, 373(9680):2034-2040.
37. Rouse D.J., Caritis S.N., Peaceman A.M. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med 2007, 357(5):454-456.
38. Caritis S.N., Rouse D.J., Peaceman A.M., et al. Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate-a randomized controlled trial. Obstet Gynecol 2009, 113(2 Pt 1):285-292.
39. Peltier M.R., Berlin Y., Tee S.C., et al. Does progesterone inhibit bacteria-stimulated interleukin-8 production by lower genital tract epithelial cells?. J Perinat Med 2009, 37(4):328-333.
40. Yellon S.M., Ebner C.A., Elovitz M.A. Medroxyprogesterone acetate modulates remodeling, immune cell census, and nerve fibers in the cervix of a mouse model for inflammation-induced preterm birth. Reprod Sci 2009, 16(3):257-264.
41. Schwartz N., Xue X., Elovitz M.A., et al. Progesterone suppresses the fetal inflammatory response ex vivo. Am J Obstet Gynecol 2009, 201(2). 211, e1-9.
42. O'Brien J.M., Adair C.D., Lewis D.F., et al. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2007, 30(5):687-696.
43. DeFranco E.A., O'Brien J.M., Adair C.D., et al. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2007, 30(5):697-705.
44. Fonseca E.B., Celik E., Parra M., et al. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007, 357(5):462-469.
45. Use of progesterone to reduce preterm birth. Obstet Gynecol 2008, 112(4):963-965. ACOG Committee Opinion No. 419.
46. Romero R., Oyarzun E., Mazor M., et al. Meta-analysis of the relationship between asymptomatic bacteriuria and preterm delivery/low birth weight. Obstet Gynecol 1989, 73(4):576-582.
47. Leitich H., Brunbauer M., Bodnar-Aderl B., et al. Antibiotic treatment of bacterial vaginosis in pregnancy: a meta-analysis. Am J Obstet Gynecol 2003, 188(3):752-758.
48. Verdenik I., Pajntar M., Leskosek B. Uterine electrical activity as predictor of preterm birth in women with preterm contractions. Eur J Obstet Gynecol Reprod Biol 2001, 95(2):149-153.
49. Grgic O., Matijevic R. Uterine electrical activity and cervical shortening in the midtrimester of pregnancy. Int J Gynaecol Obstet 2008, 102(3):246-248.
50. Garfield R.E., Maner W.L., Maul H., et al. Use of uterine EMG and cervical LIF in monitoring pregnant patient. BJOG 2005, 112(Suppl 1):103-108.
51. Marque C.K., Terrien J., Rihana S., et al. Preterm labour detection by use of a biophysical marker: the uterine electrical activity. BMC Pregnancy Childbirth 2007, 7(Suppl 1):S1-S5.